Search for: "AMGEN INC."
Results 321 - 340
of 704
Sort by Relevance
|
Sort by Date
28 Apr 2015, 9:14 am
(“Amgen”) crowd, or move to the left and side with the folks from Sandoz Inc. [read post]
7 Apr 2015, 7:44 am
Amedisys said the federal appeals courts are just as divided on this point as they were over the issues in the Amgen and Halliburton I cases, both of which the Court decided (Amedisys, Inc. v. [read post]
22 Mar 2015, 10:00 pm
District Court for the Northern District of California issued an order in Amgen, Inc. v. [read post]
26 Feb 2015, 9:43 am
Brougher On February 18, 2015, Apotex Inc., announced that the Food and Drug Administration (FDA) had accepted its application for a biosimilar version of Amgen Inc’s Neupogen®. [read post]
24 Feb 2015, 2:24 pm
Commentator Roberta Karmel noted that she had difficulty reconciling the Supreme Court’s decision in 2013 opinion in Amgen v. [read post]
12 Jan 2015, 10:24 am
Hernán Ayala, vicepresidente de operaciones de Luis Ayala Colón Sucrs, Inc.; Repte. [read post]
7 Jan 2015, 10:46 am
’s application to market Zarxio® (EP2006), a biosimilar version of Amgen, Inc. [read post]
14 Dec 2014, 9:59 pm
Amgen Inc. [read post]
12 Dec 2014, 10:29 pm
SeeAmgen Inc. v. [read post]
12 Dec 2014, 10:21 am
Catalyst Pharmaceutical Partners, Inc., 2014 WL 4814352 (S.D. [read post]
9 Dec 2014, 9:43 pm
By Andrew Williams -- Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's Enbrel® TNF inhibitor. [read post]
8 Dec 2014, 10:00 pm
Amgen Inc., the Federal Circuit upheld the district court decision dismissing Sandoz’s declaratory judgment action for lack of jurisdiction. [read post]
8 Dec 2014, 12:42 pm
” MedImmune, Inc. [read post]
3 Nov 2014, 6:58 am
Amgen, Inc., a federal securities case against Amgen based on the same events. [read post]
29 Sep 2014, 11:59 am
Amgen, Inc., No. 12-CV-476, 2014 U.S. [read post]
23 Sep 2014, 1:25 pm
by Dennis Crouch In Abbvie Inc. v. [read post]
22 Sep 2014, 4:23 am
Amerisource did not learn of the existence of the matter until March 2008, when Amgen informed Amerisource that Amgen was under investigation. [read post]
12 Aug 2014, 2:45 pm
" ______________________________________________________________________________ Relevant to the three case reports are these so-called "Dear Doctor" letters sent in late 2012 by the drug company that sells Prolia in the US and Canada to healthcare providers warning them about the risk of atypical or unusual thigh bone / femur fractures is patients using Prolia (denosumab): 9/12/12 Amgen "Dear Doctor" Letter in US: Serious risks… [read post]
29 Jul 2014, 12:08 pm
The reference product, Neupogen®, which brought maker Amgen Inc. $1.4 billion in sales in 2013, is a biologic used […] [read post]
